MyJournals Home  

RSS FeedsEvaluating the impact of public health initiatives on trends in fecal occult blood test participation in Ontario (BMC Cancer)

 
 

25 july 2014 10:37:15

 
Evaluating the impact of public health initiatives on trends in fecal occult blood test participation in Ontario (BMC Cancer)
 


Background: Since the publication of two randomized controlled trials (RCT) in 1996 demonstrating the effectiveness of fecal occult blood test (FOBT) in reducing colorectal cancer (CRC) mortality, several public health initiatives have been introduced in Ontario to promote FOBT participation. We examined the effect of these initiatives on FOBT participation and evaluated temporal trends in participation between 1994 and 2012.MethodUsing administrative databases, we identified 18 annual cohorts of individuals age 50 to 74 years eligible for CRC screening and identified those who received FOBT in each quarter of a year. We used negative binomial segmented regression to examine the effect of initiatives on trends and Joinpoint regression to evaluate temporal trends in FOBT participation. Results: Quarterly FOBT participation increased from 6.5 per 1000 in quarter 1 to 41.6 per 1000 in quarter 72 (January- March 2012). Segmented regression indicated increases following the publication of the RCTs in 1996 (Delta slope = 6%, 95% CI = 4.3-7.9), the primary care physician financial incentives announcement in 2005 (Delta slope = 2.2%, 95% CI = 0.68-3.7), the launch of the ColonCancerCheck (CCC) Program (Delta intercept = 35.4%, 95% CI = 18.3 -54.9), and the CCC Program 2-year anniversary (Delta slope = 7.2%, 95% CI = 3.9 - 10.5). Joinpoint validated these findings and identified the specific points when changes occurred. Conclusion: Although observed increases in FOBT participation cannot be definitively attributed to the various initiatives, the results of the two statistical approaches suggest a causal association between the observed increases in FOBT participation and most of these initiatives.


 
118 viewsCategory: Oncology
 
Nestin positively regulates the Wnt/ß-catenin pathway and the proliferation, survival, and invasiveness of breast cancer stem cells (Breast Cancer Research)
Early-stage lung cancer--what do the experts recommend? (Annals of Oncology)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Oncology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten